How to Detect Antibodies Against Babesia divergens in Human Blood Samples
- PMID: 38328497
- PMCID: PMC10849114
- DOI: 10.1093/ofid/ofae028
How to Detect Antibodies Against Babesia divergens in Human Blood Samples
Abstract
Background: Today only indirect fluorescent antibody assays (IFAs) are commercially available to detect antibodies against Babesia divergens in humans. IFA is subjective and requires highly experienced staff. We have therefore developed an enzyme-linked immunosorbent assay (ELISA)-based method for measuring anti-B. divergens immunoglobulin G antibodies in human blood samples.
Methods: Crude merozoite extract from in vitro cultures of a new B. divergens isolate was used in ELISA to detect antibodies in different sets of samples: Borrelia burgdorferi-positive samples, healthy individuals, tick-bitten individuals including follow-up samples 3 months later, positive control samples from patients with an active Babesia infection, and samples from malaria-endemic regions. As a reference, IFA was used to detect antibodies in the tick-bitten samples. Western blot was used to evaluate reactions against specific bands in extracts with/without parasites.
Results: Using IFA as the reference method, the sensitivity and specificity of the ELISA were 86% (12/14) and 100% (52/52). There was a very high correlation (r = -0.84; P = .0004) between IFA dilution factors and ELISA absorbances among the samples classified as positive. Five percent of the B. burgdorferi-positive samples were judged as weakly positive and 5% as strongly positive in our ELISA. Western blot showed that the immunodominant antigens (∼120 kDa) were from merozoites and not from erythrocytes.
Conclusions: This ELISA can detect antibodies directed against B. divergens, and it can be a useful and easy assay to handle compared with IFA. The ELISA can also measure high and low levels of antibodies, which could give insight into the recency of a B. divergens infection.
Keywords: Babesia; ELISA; antibody; blood transfusion; divergens.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. P.E.L. has been an external scientific expert to Valneva Austria GmbH, Vienna, Austria, and Pfizer Inc., USA. All other authors report no potential conflicts.
Figures



Similar articles
-
Evaluation of an indirect fluorescence immunoassay for the detection of serum antibodies against Babesia divergens in humans.Parasitology. 2007 Feb;134(Pt 2):179-85. doi: 10.1017/S0031182006001387. Epub 2006 Oct 11. Parasitology. 2007. PMID: 17032478
-
Development of culture-based serological assays to diagnose Babesia divergens infections.Vector Borne Zoonotic Dis. 2012 Feb;12(2):106-10. doi: 10.1089/vbz.2011.0706. Epub 2011 Oct 13. Vector Borne Zoonotic Dis. 2012. PMID: 21995263
-
Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain.Parasit Vectors. 2023 Jun 9;16(1):195. doi: 10.1186/s13071-023-05817-x. Parasit Vectors. 2023. PMID: 37296439 Free PMC article.
-
Babesia divergens: an ELISA with soluble parasite antigen for monitoring the epidemiology of bovine babesiosis.Parasite. 1995 Sep;2(3):257-62. doi: 10.1051/parasite/1995023257. Parasite. 1995. PMID: 8520800
-
Tick-borne Borrelia infection in Sweden.Scand J Infect Dis Suppl. 1985;45:1-70. doi: 10.3109/inf.1985.17.suppl-45.01. Scand J Infect Dis Suppl. 1985. PMID: 3903977 Review.
Cited by
-
Development and validation of a recombinant Rap1-based lateral flow immunoassay for rapid serodiagnosis of bovine babesiosis in Kazakhstan.Vet World. 2025 Jul;18(7):1881-1890. doi: 10.14202/vetworld.2025.1881-1890. Epub 2025 Jul 11. Vet World. 2025. PMID: 40926838 Free PMC article.
-
Research progress on diagnostic techniques for different Babesia species in persistent infections.Front Cell Infect Microbiol. 2025 May 16;15:1575227. doi: 10.3389/fcimb.2025.1575227. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40453708 Free PMC article. Review.
-
Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.Emerg Infect Dis. 2024 Sep;30(9):1934-1938. doi: 10.3201/eid3009.240556. Emerg Infect Dis. 2024. PMID: 39174031 Free PMC article.
-
Babesiosis: Analysis of the Evidence for Infections in the United Kingdom.Int J Gen Med. 2024 Oct 14;17:4627-4631. doi: 10.2147/IJGM.S485759. eCollection 2024. Int J Gen Med. 2024. PMID: 39429956 Free PMC article. Review.
References
-
- Hildebrandt A, Gray JS, Hunfeld KP. Human babesiosis in Europe: what clinicians need to know. Infection 2013; 41:1057–72. - PubMed
-
- European Centre for Disease Prevention and Control. Facts about babesiosis. Available at: https://www.ecdc.europa.eu/en/all-topics-z/babesiosis/facts-about-babesi.... Accessed March 19, 2020.
-
- Uhnoo I, Cars O, Christensson D, Nystrom-Rosander C. First documented case of human babesiosis in Sweden. Scand J Infect Dis 1992; 24:541–7. - PubMed
-
- Bläckberg J, Lazarevic VL, Hunfeld KP, Persson KEM. Low-virulent babesia venatorum infection masquerading as hemophagocytic syndrome. Ann Hematol 2018; 97:731–3. - PubMed
-
- Karlsson ME, Andersson MO. Babesia species in questing Ixodes ricinus, Sweden. Ticks Tick Borne Dis 2016; 7:10–2. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials